Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

BLACKROCK Municipal Income TRUST V.BFK.P


Primary Symbol: BFK

BlackRock Municipal Income Trust (the Fund) is a diversified closed-end management investment company. The Fund's investment objective is to provide current income exempt from federal income taxes. Under normal market conditions, the Fund invests at least 80% of its managed assets in investments the income from which is exempt from federal income tax (except that the interest may be subject to the alternative minimum tax). The Fund may invest directly in securities or synthetically through the use of derivatives. The Fund's investment policies provide that it invests at least 80% of its total assets in investment grade quality municipal obligations issued by or on behalf of states, territories and possessions of the United States and their political subdivisions, agencies or instrumentalities, each of which pays interest that, in the opinion of bond counsel to the issuer, is excludable from gross income for federal income tax purposes. Its investment adviser is BlackRock Advisors, LLC.


NYSE:BFK - Post by User

Comment by INVINCEon Jun 21, 2020 10:56am
95 Views
Post# 31174203

RE:RE:RE:Lisa Marie Langevin ???

RE:RE:RE:Lisa Marie Langevin ??? Correct wise one


HARJAY wrote:

I presume you are talking about this one.


 
 
 
 

$500M LAWSUIT ACCUSES CANNABIS RETAILERS OF DISTRIBUTING PRODUCT WITH INCORRECT THC AND CBD LEVELS

A class-action lawsuit filed in Calgary against cannabis companies claims the THC and CBD levels in their medicinal and recreational cannabis products differed from what was represented on packaging.

According to the statement of claim filed at the Judicial Centre of Calgary on Tuesday, June 16, the companies allegedly sold cannabis products to Canadian consumers with drastically different THC (tetrahydrocannabinol) or CBD (cannabidiol) levels than advertised on the label.

The defendants named in the lawsuit are:

  • Aurora Cannabis Inc.
  • Aurora Cannabis Enterprises Inc.
  • AuroraCo.
  • Aleafiaco
  • Aleafia Health Inc.
  • Emblem Cannabis Corp.
  • Hexo Corp.
  • HexoCo
  • Cronos Group Inc.
  • Cronosco
  • Tilray Canada Ltd.
  • Organigram Holdings Inc.
  • OrganigramCo
  • MediPharm Labs Corp.
  • MediPharmCo

The document indicates that THC and CBD levels were found to be significantly higher than indicated in some products while others may have had significantly lower levels as a result of absorption or degradation due to the use of plastic bottles.

 

The lawsuit is seeking $500 million in compensation for Canadians who purchased medicinal cannabis products between now and June 16, 2010 as well as Canadians who legally purchased cannabis for recreational purposes since Oct. 17, 2018.

Lisa Marie Langevin is named as the plaintiff representing the class-action. The Calgary woman claims to have purchased a cannabis oil from a northwest store in mid-February 2020 at the recommendation of a staff member.

Langevin says it was her first time trying cannabis and she did not feel any psychotropic effects after using the product four times and increasing the dosage, over the period of a month. She then consulted a friend of hers, a doctor, who also tried the product and felt nothing.

According to the statement of claim, the doctor arranged to have both the product and the plastic vial tested and it was determined that the product only had 46 per cent of the active THC level indicated on the vial's label.

The allegations outlined in the lawsuit have not been tried in court.


 

 
MORE
 
 
 
 

$500M LAWSUIT ACCUSES CANNABIS RETAILERS OF DISTRIBUTING PRODUCT WITH INCORRECT THC AND CBD LEVELS

A class-action lawsuit filed in Calgary against cannabis companies claims the THC and CBD levels in their medicinal and recreational cannabis products differed from what was represented on packaging.

According to the statement of claim filed at the Judicial Centre of Calgary on Tuesday, June 16, the companies allegedly sold cannabis products to Canadian consumers with drastically different THC (tetrahydrocannabinol) or CBD (cannabidiol) levels than advertised on the label.

The defendants named in the lawsuit are:

  • Aurora Cannabis Inc.
  • Aurora Cannabis Enterprises Inc.
  • AuroraCo.
  • Aleafiaco
  • Aleafia Health Inc.
  • Emblem Cannabis Corp.
  • Hexo Corp.
  • HexoCo
  • Cronos Group Inc.
  • Cronosco
  • Tilray Canada Ltd.
  • Organigram Holdings Inc.
  • OrganigramCo
  • MediPharm Labs Corp.
  • MediPharmCo

The document indicates that THC and CBD levels were found to be significantly higher than indicated in some products while others may have had significantly lower levels as a result of absorption or degradation due to the use of plastic bottles.

 

The lawsuit is seeking $500 million in compensation for Canadians who purchased medicinal cannabis products between now and June 16, 2010 as well as Canadians who legally purchased cannabis for recreational purposes since Oct. 17, 2018.

Lisa Marie Langevin is named as the plaintiff representing the class-action. The Calgary woman claims to have purchased a cannabis oil from a northwest store in mid-February 2020 at the recommendation of a staff member.

Langevin says it was her first time trying cannabis and she did not feel any psychotropic effects after using the product four times and increasing the dosage, over the period of a month. She then consulted a friend of hers, a doctor, who also tried the product and felt nothing.

According to the statement of claim, the doctor arranged to have both the product and the plastic vial tested and it was determined that the product only had 46 per cent of the active THC level indicated on the vial's label.

The allegations outlined in the lawsuit have not been tried in court.




<< Previous
Bullboard Posts
Next >>